Skip to main content
Premium Trial:

Request an Annual Quote

Witec to Sell Fluidigm's Microfluidic Circuits in Switzerland

NEW YORK (GenomeWeb News) – Swiss company Witec AG will exclusively distribute Fluidigm’s Integrated Fluidic Circuit system to life sciences research customers in Switzerland, Fluidigm said today.
 
Fluidigm’s BioMark System uses integrated fluidic circuits with a matrix of channels, valves, and chambers on a silicone chip to conduct over two thousand experiments at one time, the South San Francisco, Calif.-based company said.
 
Fluidigm’s fluidic systems have not been cleared by the US Food and Drug Administration for diagnostic use and are sold only for research purposes, the firm noted.

The Scan

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

New Insights Into TP53-Driven Cancer

Researchers examine in Nature how TP53 mutations arise and spark tumor development.

Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer

In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer.

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.